Eustaquio Lab

@eustaquiolab.bsky.social

We study natural products (secondary metabolites) from bacteria using genomics, reverse genetics, and synthetic biology approaches. University of Illinois at Chicago eustaquio.lab.uic.edu

🔓Be sure to read this #OpenAccess Highlight by Barbara I. Adaikpoh from the University of Illinois Chicago in our latest issue looking at microbial natural products activated by plant stress #natprod #secmet Find the full article on our website👇

Microbial natural products activated by plant stress

Covering: 2000 to August 2025 The search for new antimicrobial natural products from microorganisms has been limited by the transcriptional silencing of biosynthetic genes when microbes are…

pubs.rsc.org

The MIBiG 5.0 Annotathon is coming soon, and registration is now open! 🧬 Does your research involve biosynthetic gene clusters? Do you love natural product biosynthesis? Do you have an interest in rare & exotic enzymes? We can use your help & expertise. Register here 👉 forms.gle/C1cWcLHtrjT2...

Bild

Lovely C&EN @cenmag.bsky.social story on the history and personal impact of the cancer drug Taxol. After spending recent years deciphering how yew trees, our source for Taxol, synthesize this lifesaving drug, it’s so nice to see it in the larger context #secmet #medsky Plants are amazing chemists.

Paclitaxel saved my life. New discoveries could boost supply

After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug

cen.acs.org

Be sure to read this review, part of our Industrial Perspective themed collection, by Stefano Donadio & co. from NAICONS Srl discussing the trends in metabolite discovery from Actinomycetes #secmet #natprod Find it in full below👇

Trends in metabolite discovery from Actinomycetes

Covering: 2013 to 2023 In this review, we analyzed the scientific literature of the period 2013–2023 that reported novel specialized metabolites from the Actinomycetes, one of the most prolific…

pubs.rsc.org

Come read about our thoughts on why cyanobacteria are underrepresented in drug discovery and how both synthetic biology and native hosts can help. This was fun to work on with a great group of people who include @dtdoering.bsky.social @danudwary.secondarymetabolism.com @eustaquiolab.bsky.social

Dan Udwary@danudwary.secondarymetabolism.com · last yr.

Here's a fun perspective piece on Cyanobacteria as prolific natural product producers with great potential for drug discovery. Thanks especially to @philmuslab.bsky.social for ringleading and letting us contribute! pubs.rsc.org/en/content/a...

Pleased to share our new paper out in 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘐𝘯𝘷𝘦𝘴𝘵𝘪𝘨𝘢𝘵𝘪𝘰𝘯 led by Monika Kumaraswamy, MD, now Chief of Infectious Diseases UTexas-Tyler Is minimimum inhibitory concentration (MIC) testing the gold standard for antibiotic-resistant superbugs? 🦠 🧫 🧵 1/6 www.jci.org/articles/vie...

Bild

New report shows that NIH grants fueled $95 billion in economic activity and 407,782 jobs in 2024. That's not to mention the countless lives that biomedical research has saved. Show me a better investment than that. www.forbes.com/sites/michae...

NIH Grants Fueled $95 Billion In FY 2024 Economic Activity, Finds New Report

National Institutes of Health grants generated almost $95 billion in economic activity nationwide in FY 2024 according to a new report by United for Medical Research.

forbes.com